izpis_h1_title_alt

Covalently conjugated NOD2/TLR7 agonists are potent and versatile immune potentiators
ID Guzelj, Samo (Author), ID Weiss, Matjaž (Author), ID Slütter, Bram (Author), ID Frkanec, Ruža (Author), ID Jakopin, Žiga (Author)

.pdfPDF - Presentation file, Download (4,87 MB)
MD5: 8D39BBED6CCD63450262B15C5E707607
URLURL - Source URL, Visit https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.2c00808 This link opens in a new window

Abstract
The success of vaccination with subunit vaccines often relies on the careful choice of adjuvants. There is great interest in developing new adjuvants that can elicit a cellular immune response. Here, we address this challenge by taking advantage of the synergistic cross-talk between two pattern recognition receptors: nucleotide-binding oligomerization-domain-containing protein 2 (NOD2) and Toll-like receptor 7 (TLR7). We designed two conjugated NOD2/TLR7 agonists, which showed potent immunostimulatory activities in human primary peripheral blood mononuclear cells and murine bone-marrow-derived dendritic cells. One of these, 4, also generated a strong antigen-specific immune response in vivo, with a Th1-polarized profile. Importantly, our study shows that novel NOD2/TLR7 agonists elicit sophisticated and fine-tuned immune responses that are inaccessible to individual NOD2 and TLR7 agonists.

Language:English
Keywords:immunostimulatory activity, vaccines, immune responses, pattern recognition receptors, synthesis of NOD2 agonist, Toll-like receptor 7
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:Str. 15085–15101
Numbering:Vol. 65, iss. 22
PID:20.500.12556/RUL-143233 This link opens in a new window
UDC:615.371:616-097
ISSN on article:1520-4804
DOI:10.1021/acs.jmedchem.2c00808 This link opens in a new window
COBISS.SI-ID:128189187 This link opens in a new window
Publication date in RUL:09.12.2022
Views:363
Downloads:122
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Journal of medicinal chemistry
Shortened title:J. med. chem.
Publisher:American Chemical Society
ISSN:1520-4804
COBISS.SI-ID:512806681 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:imunostimulatorna aktivnost, imunski odziv, receptorji za prepoznavanje vzorcev, sinteza agonista NOD2, receptor TLR7, cepiva

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Funder:ARRS - Slovenian Research Agency
Project number:P1-0420
Name:Napredna imunološka zdravila in celični pristopi v farmaciji

Funder:ARRS - Slovenian Research Agency
Project number:J3-9256
Name:Razvoj agonistov receptorja NOD2 ter dualnih NOD2/TLR7 agonističnih konjugatov kot novih adjuvansov za cepiva

Funder:HRZZ - Croatian Science Foundation
Project number:IP-2018-01-6910
Name:Sinteza supramolekulskih samo-udruženih nanostruktura za izgradnju naprednih funkcionalnih materijala

Funder:ARRS - Slovenian Research Agency
Project number:BI-HR/18-19-001

Funder:HRZZ - Croatian Science Foundation
Funding programme:Bilateral contract

Funder:Other - Other funder or multiple funders
Funding programme:COST
Project number:CA16231
Name:European Network of Vaccine Adjuvants
Acronym:ENOVA

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back